 TORONTO--BUSINESS WIRE--- HUGE--FSD Pharma Inc. Nasdaq: HUGE CSE: HUGE FSD Pharma or the Company today announces that it has entered into a license agreement the License Agreement with Innovet Italia S.R.L. Innovet, under which Innovet granted the Company a license to use ultramicronized-palmitoylethanolamide or ultramicronized PEA ultra-micro PEA to develop U.S. Food and Drug Administration FDA approved veterinary drugs for the treatment of gastro-intestinal diseases in C 